Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension

Clinical Cardiology

Volumn 27, Issue 6 SUPPL. 3, 2004, Pages 347-350

  Karlsson, J ^a   Lind, L ^a,b   Hallberg, P ^a   Michaelsson K ^a   Kurland, L ^a   Kahan, T ^c   Malmqvist, K ^c   Ohman K P ^b,d   Nystrom F ^d   Melhus, Håkan ^a,e  

^a UPPSALA UNIVERSITY   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenoceptor; Atenolol; Beta1 adrenergic receptor; Gene; Hypertension; Pharmacogenetics; Polymorphism

Indexed keywords

ARGININE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCINE; IRBESARTAN; SERINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ALLELE; ARTICLE; BETA 1 ADRENERGIC RECEPTOR GENE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; EVALUATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; BLOOD PRESSURE; DRUG EFFECT; GENETICS; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ALLELES; ATENOLOL; BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA;

EID: 2542618304     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270610     Document Type: Article

References (18)

1. 1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 1999;96:7059-7064
2. 1-adrenergic receptor gene: Developmental and cardiovascular effects. Proc Natl Acad Sci USA 1996;93:7375-7380
3. 2-adrenergic receptors. J Biol Chem 1999;274:16701-16708
4. Strader CD, Fong TM, Tota MR, Underwood D, Dixon RA: Structure and function of G protein-coupled receptors. Ann Rev Biochem 1994;63:101-132
5. 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999;31:1025-1032
6. 1-adrenoceptor: Identification and rapid screening assay (letter). Lancet 1999;353:897
7. 1-adrenergic receptor. J Biol Chem 1999;274:12670-12674
8. Moore JD, Mason DA, Green SA, Hsu J, Liggett SB: Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: Analysis of c145A>G and c1165G>C (letter). Hum Mutat 1999;14:271
9. Börjesson M, Magnusson Y, Hjalmarson A, Andersson B: A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000;21:1853-1858
10. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Öhman KP, Nyström F, Hagg A, Lind L: Angiotensin-converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type I antagonist treatment in hypertensive patients. J Hypertens 2001;19:1783-1787
11. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Öhman P, Nyström F, Hagg A, Lind L: Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: Result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens 2002;15:389-393
12. Malmqvist K, Kahan T, Edner M, Held C, Hagg A, Lind L, Muller-Brunotte R, Nyström F, Öhman KP, Osbakken MD, Ostergern J: Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 2001;19:1167-1176
13. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y: The myocardium-protective Gly49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and downregulation. J Biol Chem 2002;277:30429-30435
14. Rathz DA, Brown KM, Kramer LA, Liggett SB: Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002;39:155-160
15. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT, Chen YD, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N: A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002;70:935-942
16. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Rastam L, Groop L: Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 2001;104:187-190
17. Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM: Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-197
18. Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S, Hoyer PF, Michel MC, Insel PA, Brodde OE: In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001;11:199-205